New SEC Form D filing

Mercury Bio, Inc., 2026-11-13

A new SEC Form D private-offering notice from Santa Fe, NM, a $1,589,992 filer-stated offering target in Biotech. The source filing is one click away.

What this filing says

Mercury Bio, Inc. site↗ Verified via SEC Form D

Biotech developing intracellular immunotherapies and a cell delivery platform (yEV, MB-TIP) targeting neurodegenerative diseases like Parkinson's and Alzheimer's

Filed 6 days agoFiled to raise $1,589,992First money in 2026-10-29Raised so far $1,589,992HQ (as filed) Santa Fe, NMSector Biotech web-verified against the company’s own siteStage (inferred) SeedCall status Call-ready
Source linked the Form D on EDGAR↗Website verified mercurybio.com↗Named in the filing 8 executives & directors

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source